Switzerland· 54785038
Polvac Bäume 2000 SU/0.5 ml, Injektionssuspension in einer Fertigspritze
A baumpollen product containing pollinis allergeni extractum, registered in Switzerland by Bencard AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Baumpollen is registered in 12 of 19 countries.
Countries holding a registration under ATC V01AA05 (baumpollen), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Baumpollen · ATC V01AA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- pollinis allergeni extractum
- Manufacturer
- Bencard AG
- Country
- Switzerland (CH)
- ATC code
- V01AA05
- ATC class
- Baumpollen
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76805478503873x 0.5 mlCHF 296.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V01AA05
Baumpollen, as other registers publish it.
- DenmarkAlk (108) Betula VerrucosaALK-Abello A/S
- DenmarkAlk (108) Betula VerrucosaALK-Abello A/S
- SwitzerlandAllergovit Alnus/Corylus
- SwitzerlandAllergovit Alnus/Corylus
- SwitzerlandAllergovit Betula
- SwitzerlandAllergovit Betula
- SwitzerlandAllergovit Betula/Alnus/Corylus
- SwitzerlandAllergovit Betula/Alnus/Corylus
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdf793e1-e629-4e8d-8f8e-ee2b6320e25a GET /v1/drugs/cdf793e1-e629-4e8d-8f8e-ee2b6320e25a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "pollinorum allergenorum extractum 2000 U",
"valid_from": "2004-03-01",
"limitations": "[{\"description\":\"Zur prä-saisonalen spezifischen Immuntherapie von allergischen (IgE-vermittelten) Krankheiten, wie allergisch bedingter Schnupfen (Rhinitis), allergisch bedingte Entzündung der Augenbindehaut (Konjunktivitis), allergisches Asthma bronchiale usw., die durch Pollen ausgelöst werden.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2021-02-01\"}]",
"galenic_form": "Inj Susp Fertspr",
"therapeutic_area": null,
"sl_inclusion_date": "2001-09-01",
"self_retention_pct": 10
}See everything about baumpollen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.